Nicholas: Benefits from merger - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Nicholas: Benefits from merger

Jan 25, 2002

Nicholas Piramal India has posted a 64% jump in revenues and a 78% jump in PBT for the quarter ended December'01. This is however, due to the merger with Rhone Poulenc India and hence the results are not comparable.

(Rs m)3QFY013QFY02% change
Net Sales 1,181 1,931 63.5%
Other Income 19 26 31.4%
Expenditure 984 1,568 59.4%
Operating Profit (EBDIT) 197 363 83.9%
Operating Profit Margin (%)16.7%18.8% 
Interest 34 84 145.6%
Depreciation 36 44 21.2%
Profit before Tax14626078.1%
Extraordinary Items -52 
Tax 12 77 540.8%
Profit after Tax/(Loss) 134 132 -2.0%
Net profit margin (%)11.4%6.8% 
Diluted number of shares 34.9 38.0  
Diluted Earnings per share*14.113.8 
P/E (at current price)   
*(annualised)   

The company recorded a 210 basis point jump in operating margins. However, interest cost has gone up sharply on account of borrowings for acquisition for Rhone-Poulenc which accounted for 80% of the borrowing cost. During the current quarter, the company incurred VRS and restructuring costs for its Bhandup plant. However, the company has changed the accounting policy with regard to writing off of VRS cost with restrospective effect from April'01. Earlier the company used to fully write off VRS expenses in the year it was incurred. However, the same would now be written off over a period of 60 months. Consequent to the above change, the charge for VRS in the current quarter is lower by Rs 260 m.

Tax provision leapfrogged due to new accounting policy on deffered taxation. Further, the tax rebate hirtherto available to the company for its plant in backward area was no longer available. The increase in share capital is on account of shares issued to shareholders of Rhone-Poulenc India as per the merger.

On a like to like to basis, sales have improved by around 8%, operating margins have shown a healthy improvement of 390 basis points. Profit before tax, however, registered a negative growth due to heavy rise in interest burden as explained earlier. Cash flows from sale of Rhone's property is expected to reduce interest burden going forward.

Interest costs: Spoiling the show
Rs m3QFY013QFY02% change
Sales1791 1,931 7.8%
Operating Profit26736336.2%
Operating Profit Margin (%)14.9%18.8% 
Interest3584140.0%
PBT 277260-6.1%

At the current market price of Rs 225, the stock trades on a P/E of 10.7x expected earnings for FY02. The benefits due to synergies in operations, reduction in working capital requirements and savings in interest cost is expected to happen only in the next year. Valuations going forward would look attractive if the management is able to achieve a fast payback from its acquisition, as expected.

Equitymaster requests your view! Post a comment on "Nicholas: Benefits from merger". Click here!

  

More Views on News

PIRAMAL ENTERPRISES 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY22); Net Profit Down 20.0% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (down 20.0% YoY). Sales on the other hand came in at Rs 29 bn (down 1.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for (Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology (Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Dec 6, 2021 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - DISHMAN PHARMA COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS